The Master of Science in BioTherapeutics is a two-year, full-time on-campus program that focuses on the development and application of biological therapies in the biomedical field. The program covers a range of topics, including drug development, molecular biology, and the use of biopharmaceuticals in treating diseases. Students will engage in both theoretical and practical training, gaining hands-on experience in the production and testing of bio-based therapies.
Graduates will be well-prepared for careers in biopharmaceutical development, clinical research, and biotechnology. Leiden University offers access to advanced research facilities, industry partnerships, and expert faculty, providing students with the knowledge and skills needed for a successful career in the growing field of bio therapeutics.
Key Facts
Key Facts
- Program Title: BioTherapeutics
- Degree Type: Master of Science
- Duration: 2 years
- Mode of Study: Full-time, On Campus
- Application Deadline: 01 April 2026
- Location: Leiden University, Netherlands
- Field of Study: Biomedical Science
- Language of Instruction: English
Program Structure
Semester 1 – Foundations in BioTherapeutics
- Introduction to BioTherapeutics
- Pharmaceutical Biotechnology and Drug Development
- Molecular Biology and Biochemistry for BioTherapeutics
- Research Methods in BioTherapeutics
Semester 2 – Advanced BioTherapeutics
- Biopharmaceuticals and Protein Engineering
- Immunotherapy and Gene Therapy
- Drug Delivery Systems and Targeted Therapies
- Research Project in BioTherapeutics
Semester 3 – Applied BioTherapeutics
- Clinical Applications of BioTherapeutics
- Regulatory Affairs and Bioethics in Drug Development
- Biopharmaceutical Manufacturing and Quality Control
- Research Project in Applied BioTherapeutics
Semester 4 – Master’s Thesis & Final Project
- Independent Research / Thesis
- Data Analysis in BioTherapeutics
- Presentation & Academic Portfolio Development
Career Opportunities
Graduates of the BioTherapeutics Master’s program can work in pharmaceutical development, biotechnology, and therapeutic research. With expertise in biopharmaceuticals, drug development, and therapeutic innovations, graduates are prepared for roles as biomedical researchers, drug development specialists, or clinical trial coordinators. This program provides opportunities in biotech companies, pharmaceutical firms, and research institutions focused on therapeutic solutions.
Why Choose This Program
The BioTherapeutics Master’s program provides students with a deep understanding of the science behind biologics, drug development, and therapeutic applications. Students learn to develop and test new biotherapeutics, including monoclonal antibodies, vaccines, and gene therapies. The program’s practical training in research labs and real-world applications ensures that graduates are well-prepared for careers in pharmaceutical and biotechnology industries. Graduates are ready to contribute to the development of next-generation therapeutic treatments.
Contact Information
For further information, please contact the admissions office at:
Phone: +31 (0)71 527 1111
Email: study@leidenuniv.nl
Address: Leiden University, Rapenburg 70, 2311 EZ Leiden, Netherlands
